全福生技 News Releases

QuanFu Biotech Announces Completion of Capital Reduction due to Cancellation of Employee Stock Rights Shares

QuanFu Biotech announced the completion of its capital reduction registration following the cancella… · 2026-04-09

QuanFu Biotech Announces Completion of Capital Reduction due to Cancellation of Employee Stock Rights Shares

QuanFu Biotech announced the completion of its capital reduction registration following the cancella… · 2026-04-09

【BRIM Biotechnology】March 2026 Revenue NT$0.01 Billion (YoY +3548.5%)

Biopharmaceutical company BRIM Biotechnology (6885) announced that its monthly revenue for March 202… · 2026-03-01

[GNT Biotech] February 2026 Revenue: 0.01 Hundred Million TWD (YoY +1758.8%)

GNT Biotech (6885) announced its financial report for February 2026. The company's revenue for the m… · 2026-02-01

[Fullhope Biotech] Announcement of Full Board of Directors Reshuffle at 115th Annual General Meeting of Shareholders

Fullhope Biotech Inc. has announced a full reshuffle of its board of directors at the 115th Annual G… · 2026-06-12

Quan Fu Biotech Announces Key Resolutions from 115th Annual Shareholders' Meeting

Quan Fu Biotech held its 115th annual shareholders' meeting on June 12, 2026, approving key resoluti… · 2026-06-12

[Fullhope Biotech] Announcement of Changes in Audit Committee Members

The term of the audit committee of Fullhope Biotech has ended, and Guo Zongming, Cheng Shouzhen, and… · 2026-06-12

Chuan Fu Biotech Announces Board Resolution on Appointment of Chairman

Chuan Fu Biotech's board of directors has resolved to reappoint Lin Chun as Chairman effective June … · 2026-06-12

[Full Fortune Biotech] Announcement of Compensation Committee Member Changes

The compensation committee members of Full Fortune Biotech Inc. have changed due to the end of their… · 2026-06-12

[Zhenfu Life Technology] Shareholders' Meeting Approves Resolution to Lift Competition Restrictions on New Directors (Including Independent Directors) and Their Representatives

Zhenfu Life Technology held its shareholders' meeting on June 12, 115, and approved a resolution to … · 2026-06-12

BRIM Biotechnology Reports May 2026 Revenue of NT$0.82 Million, Down 27.9% YoY

BRIM Biotechnology (6885) announced its consolidated revenue for May 2026 at NT$822,000 (approx. NT$… · 2026-05-01

[All 福生技] Supplemental Announcement on the Board Meeting for the Q1 115 Consolidated Financial Report (Scheduled Date: May 7, 115)

All 福生技 announced that a board meeting to approve the Q1 115 consolidated financial report will be h… · 2026-04-29

All Fortune Biotech Announces April 2026 Revenue of 0.01 Billion (up 2152.9% YoY)

All Fortune Biotech reported April 2026 revenue of 0.01 billion, a significant year-over-year increa… · 2026-04-01

All-Bio Science Inc. Announces Board Approval of Q1 2026 Consolidated Financial Statements

All-Bio Science Inc. announced that its Board of Directors approved the consolidated financial state… · 2026-05-07

Allyes Biotech: Board of Directors Resolves to Issue Common Shares through Global Depository Receipts for Capital Increase

Allyes Biotech's Board of Directors resolved to conduct a capital increase by issuing up to 40 milli… · 2026-05-07

【BRIM Biotechnology】March 2026 Revenue NT$0.01 Billion (YoY +3548.5%)

Biopharmaceutical company BRIM Biotechnology (6885) announced that its monthly revenue for March 202… · 2026-03-01

[GNT Biotech] February 2026 Revenue: 0.01 Hundred Million TWD (YoY +1758.8%)

GNT Biotech (6885) announced its financial report for February 2026. The company's revenue for the m… · 2026-02-01

All Fortune Biotech Announces April 2026 Revenue of 0.01 Billion (up 2152.9% YoY)

All Fortune Biotech reported April 2026 revenue of 0.01 billion, a significant year-over-year increa… · 2026-04-01

All-Bio Science Inc. Announces Board Approval of Q1 2026 Consolidated Financial Statements

All-Bio Science Inc. announced that its Board of Directors approved the consolidated financial state… · 2026-05-07

Allyes Biotech: Board of Directors Resolves to Issue Common Shares through Global Depository Receipts for Capital Increase

Allyes Biotech's Board of Directors resolved to conduct a capital increase by issuing up to 40 milli… · 2026-05-07